查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1656908

血氣·電解質分析設備:市場洞察·競爭情形·市場預測 (～2032年)

Blood Gas and Electrolyte Analyzers - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

血氣和電解質分析儀市場規模預計將從 2024 年的 25.1765 億美元增長到 2032 年的 38.9167 億美元，預測期內的複合年增長率為 5.65%。

血氣和電解質分析儀的需求主要受到心血管疾病、呼吸系統疾病、腎臟疾病和糖尿病等慢性疾病盛行率不斷上升的推動。這些疾病在老年人口成長中尤其普遍。此外，即時診斷（POCT）的日益普及使得快速的現場診斷成為可能，這也促進了市場的成長。隨著主要參與者推出新產品，小型化、便攜式和自動化分析儀器等技術進步也進一步推動了市場擴張。預計所有這些因素都將在預測期內（2025 年至 2032 年）推動市場成長。

血氣與電解質分析儀市場動態：

根據英國心臟基金會2024年9月發布的數據，全球約有6.4億人受到心臟和循環系統疾病的影響，預計未來幾年這一數字還會增加。該基金會進一步指出，每年約有 6,700 萬人被診斷出患有心臟或循環系統疾病。

同樣，全球糖尿病負擔也迅速增加。國際糖尿病聯盟2023年報告稱，2021年20-79歲成年人患糖尿病的數量將增至5.37億，2030年將增至6.43億，2045年將增至7.83億。

按產品類型劃分，預計設備部門將在 2024 年佔據相當大的收入佔有率。血氣和電解質分析儀可以測量多種生命參數，包括血液氣體（pH、pO2、pCO2 等）和電解質（鈉、鉀、氯、鈣等）。這些設備使醫療專業人員能夠全面評估患者的代謝和呼吸狀況。

除了這些優點之外，血氣和電解質分析儀的技術進步也推動了市場的成長。

本報告提供全球血氣·電解質分析設備的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 血氣·電解質分析設備市場報告:簡介

  • 調查範圍
  • 市場區隔
  • 市場前提條件

第2章 血氣·電解質分析設備市場:摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 血氣·電解質分析設備市場:主要要素分析

  • 推動市場要素
    • 慢性病發生率上升
    • 老年人口不斷增加
    • 擴大採用即時診斷檢測 (POCT)
    • 各大公司的技術進步和新產品發布
  • 市場限制與課題
    • 血氣和電解質分析儀成本高
    • 設備故障與校準錯誤
  • 市場機會
    • 人工智慧、機器學習和物聯網等先進技術的集成
    • 對早期準確診斷的需求和認識不斷提高

第6章 血氣·電解質分析設備市場:波特的五力分析

第7章 血氣·電解質分析設備市場評估

  • 各產品類型
    • 設備
    • 消耗品
  • 各類型
    • 可攜式
    • 桌面式
  • 各終端用戶
    • 醫院
    • 診斷實驗室
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 血氣·電解質分析設備市場:企業·產品簡介

  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Horiba Medical
  • Medica Corporation
  • Nova Biomedical
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Sensa Core Medical
  • OPTI Medical Systems, Inc.
  • B&E BIO-TECHNOLOGY CO., LTD.
  • Scitek Global Co., Ltd.
  • i-SENS, Inc.
  • Techno MedicaCo., Ltd.
  • Trivitron Healthcare
  • Randox Laboratories Ltd.
  • Agilent Technologies, Inc.
  • Infitek Co., Ltd.
  • Chengdu Seamaty Technology Co., Ltd.

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明·聯絡方式

Product Code: DIMDCL0393

Blood Gas and Electrolyte Analyzers Market by Product Type (Instruments and Consumables), Type (Portable and Bench-top), End-User (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of chronic diseases and technological advancements in devices

The blood gas and electrolyte analyzers market was valued at USD 2,517.65 million in 2024, growing at a CAGR of 5.65% during the forecast period from 2025 to 2032 to reach USD 3,891.67 million by 2032. The demand for blood gas and electrolyte analyzers is primarily driven by the increasing prevalence of chronic diseases cardiovascular, respiratory, and kidney diseases, along with conditions such as like diabetes. These conditions are particularly common among the growing geriatric population, which is more prone to develop such ailments. Additionally, the rising adoption of Point-of-Care Testing (POCT) enables faster, on-site diagnosis, thus contributing to market growth. Technological advancements such as smaller, portable, and automated analyzers, along with new product launches by key players, further enhance the market's expansion. All these factors are expected to drive the growth of the blood gas and electrolyte analyzers market during the forecast period from 2025 to 2032.

Blood Gas and Electrolyte Analyzers Market Dynamics:

According to data published by the British Heart Foundation in September 2024, approximately 640 million people globally were affected by heart and circulatory diseases, with these numbers anticipated to rise in the coming years. The same source further stated that around 67 million individuals are diagnosed with heart or circulatory diseases each year.

Similarly, the global diabetes burden is rising rapidly. The International Diabetes Federation reported in 2023 that 537 million adults aged 20-79 were living with diabetes in 2021, with the number expected to increase to 643 million by 2030 and 783 million by 2045.

According to the Asthma and Allergy Foundation of America in 2022, in the United States, asthma was a significant health concern affecting over 22 million adults aged 18 and older. Similarly, data from the Australian Bureau of Statistics in December 2023, the prevalence of asthma is increased from 2.7 million people in 2021 to 2.8 million in 2022. In general, females exhibited a higher propensity for asthma as compared to males, with a prevalence rate of 12.2% versus 9.4%.

Similarly, data from the International Society of Nephrology in 2023 estimated that approximately 850 million people were suffering from chronic kidney diseases in 2023 worldwide.

As the number of people suffering from chronic conditions such as diabetes, heart disease, and respiratory diseases continues to grow, the demand for blood gas and electrolyte analyzers is also expected to grow, as these devices are used to measure blood gas and electrolyte balance which is critical in the diagnosis of these conditions. Therefore, the rising prevalence of chronic disease is driving the market growth.

The increase in chronic diseases can largely be attributed to the growing aging population, which is more vulnerable to develop these conditions. According to the United Nations World Social Report 2023, the global population aged 65 years and older is projected to double over the next few decades, rising from 761 million in 2021 to an estimated 1.6 billion by 2050. This significant rise in the number of elderly individuals contributes directly to the growing prevalence of age-related chronic diseases. As a result, the expanding geriatric population is playing a key role in driving the blood gas and electrolyte analyzers market.

Additionally, key players in the market are actively developing and commercializing blood gas and electrolyte analyzers for both clinical and laboratory settings, which is further fueling market growth. For example, in December 2022, Biobase launched the BKE Series Electrolyte Analyzer. This advanced analyzer utilizes ion-selective electrode measurement technology to directly measure the concentrations of key ions and pH in various samples, including serum, plasma, whole blood, cerebrospinal fluid, and diluted urine. Known for its speed, accuracy, and ease of use, the BKE Series is designed to be a highly practical tool for clinical testing. The launch of such innovative products by major players is significantly driving the growth of the blood gas and electrolyte analyzers market.

However, the high cost associated with blood gas and electrolyte analyzers, device malfunction and calibration errors, among others are some of the key constraints that may limit the growth of the blood gas and electrolyte analyzers market.

Blood Gas and Electrolyte Analyzers Market Segment Analysis:

Blood Gas and Electrolyte Analyzers Market by Product Type (Instruments and Consumables), Type (Portable and Bench-top), End-User (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the blood gas and electrolyte analyzers market, the instruments category is estimated to amass a significant revenue share in 2024. The growth of the blood gas and electrolyte analyzer market can be attributed to the various advantages and applications offered by these instruments. Blood gas and electrolyte analyzers measure a wide range of critical parameters, including blood gases (such as pH, pO2, pCO2) and electrolytes (such as sodium, potassium, chloride, and calcium). These instruments enable healthcare professionals to conduct a comprehensive assessment of a patient's metabolic and respiratory status.

The ability to provide quick results, often within minutes, is especially crucial in critical care settings, where timely decision-making can significantly impact patient outcomes. Many analyzers are portable, making them ideal for bedside testing, which reduces the turnaround time for results and facilitates immediate clinical decisions in emergency situations, ultimately enhancing patient care and improving efficiency in urgent medical environments.

In addition to these advantages, technological advancements in blood gas and electrolyte analyzers are further driving market growth. For instance, in July 2022, EDAN Instruments launched the first-ever Point-of-Care (POC) fluorescence-based CO-OX blood gas and chemistry analysis system, the i20. This cutting-edge analyzer, equipped with over 45 parameters, covers a wide range of tests, from blood gases and electrolytes to CO-oximetry. The i20 utilizes photoluminescence biosensor technology combined with microfluidics, enabling it to provide rapid and accurate results, marking a significant advancement in the blood gas and electrolyte analyzer instruments.

North America is expected to dominate the overall blood gas and electrolyte analyzers market:

North America is expected to hold the largest market share of the blood gas and electrolyte analyzers market in 2024, among all the regions. This can be attributed to the increasing prevalence of chronic diseases such as cardiovascular conditions, respiratory disorders, and kidney diseases, which are more common among the growing geriatric population in the region. Additionally, the rising demand for rapid diagnosis, coupled with technological advancements and new product launches by key market players, is further propelling the market growth. The region's developed healthcare infrastructure and sophisticated medical facilities also play a significant role in driving the adoption of advanced diagnostic tools like blood gas and electrolyte analyzers, making North America a key player in this market.

According to the data from the Centers for Disease Control and Prevention (CDC) in 2024, approximately 4.9% of adults were diagnosed with coronary heart disease (CHD) in 2022 in the United States.

According to the recent data and stats provided by American Lung Association (2024), more than 34 million people living in the U.S. live with a chronic lung disease like asthma and COPD. Both COPD and asthma require regular tracking of vital signs such as oxygen saturation, heart rate, and respiratory rate to manage symptoms, prevent exacerbations, and avoid hospitalizations, thus boosting the overall market of blood gas and electrolyte analyzers.

Also, according to data from the American Diabetes Association (2023), approximately 38.4 million people, or 11.6% of the population, were living with diabetes in 2021 in the United States. Among these individuals, 29.7 million had received a diagnosis, while an estimated 8.7 million remained undiagnosed.

Therefore, the increasing prevalence of chronic diseases necessitates regular monitoring and comprehensive testing to manage patient outcomes effectively. As a result, there is a growing reliance on blood gas and electrolyte analyzers, thus driving the market growth.

Key players in the region are focusing their efforts on technological innovations to develop advanced products integrated with cutting-edge technologies. For example, in October 2023, Nova Biomedical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for a micro capillary sample mode on the Stat Profile Prime Plus(R) Critical Care Analyzer. This new feature allows the analyzer to perform an 11-test panel, including pH, PCO2, PO2, Na, K, iCa, iMg, Cl, glucose, lactate, and hematocrit, using just 90 microliters of capillary blood. Additionally, it can conduct a complete 22-test profile with only 135 microliters of blood. Such product innovations are further accelerating the growth of the blood gas and electrolyte analyzers market in the region by improving efficiency, speed, and accuracy in critical care settings.

Blood Gas and Electrolyte Analyzers Market Key Players:

Some of the key market players operating in the blood gas and electrolyte analyzers market include Abbott Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Horiba Medical, Medica Corporation, Nova Biomedical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Sensa Core Medical, OPTI Medical Systems, Inc., B&E BIO-TECHNOLOGY CO., LTD., Scitek Global Co., Ltd., i-SENS, Inc., Techno MedicaCo., Ltd., Trivitron Healthcare, Randox Laboratories Ltd., Techno MedicaCo., Ltd., Infitek Co., Ltd., Chengdu Seamaty Technology Co., Ltd., and others.

Recent Developmental Activities in the Blood Gas and Electrolyte Analyzers Market:

  • In June 2023, B&E Bio-Technology launched the i-Check handheld blood gas electrolyte analyzer. i-Check is a portable, dry blood gas analyzer that integrates advanced technologies such as microfluidic control, integrated electrodes, and standard liquid microencapsulation. Its handheld design offers exceptional convenience, allowing for quick and efficient testing in various healthcare settings.
  • In July 2022, Radiometer, a Danaher company, partnered with robotic technology provider Technicon to introduce a robotic solution for the ABL800 FLEX Blood Gas Analyzer. This innovative robotic solution automates the handling of test tubes on the analyzer, streamlining data registration and sample testing processes. By reducing the need for manual labor, this advancement improves efficiency, accuracy, and throughput, further enhancing the performance of the ABL800 FLEX in clinical settings.

Key Takeaways from the Blood Gas and Electrolyte Analyzers Market Report Study

  • Market size analysis for current Blood Gas and Electrolyte Analyzers Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the Blood Gas and Electrolyte Analyzers market.
  • Various opportunities available for the other competitors in the Blood Gas and Electrolyte Analyzers Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Blood Gas and Electrolyte Analyzers market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Blood Gas and Electrolyte Analyzers market growth in the coming future?

Target Audience who can be benefited from this Blood Gas and Electrolyte Analyzers Market Report Study

  • Blood Gas and Electrolyte Analyzers product providers
  • Research organizations and consulting companies
  • Blood Gas and Electrolyte Analyzers related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Blood Gas and Electrolyte Analyzers
  • Various end-users who want to know more about the Blood Gas and Electrolyte Analyzers Market and the latest technological developments in the Blood Gas and Electrolyte Analyzers Market.

Frequently Asked Questions for the Blood Gas and Electrolyte Analyzers Market:

1. What are Blood Gas and Electrolyte Analyzers?

  • Blood Gas and Electrolyte Analyzers are medical devices used to measure the levels of blood gases (such as pH, pO2, pCO2) and electrolytes (such as sodium, potassium, chloride, calcium, and bicarbonate) in a patient's blood or other biological samples. These analyzers provide essential information about a patient's respiratory function, metabolic state, and electrolyte balance.

2. What is the market for Blood Gas and Electrolyte Analyzers?

  • The blood gas and electrolyte analyzers market was valued at USD 2,517.65 million in 2024, growing at a CAGR of 5.65% during the forecast period from 2025 to 2032 to reach USD 3,891.67 million by 2032.

3. What are the drivers for the Blood Gas and Electrolyte Analyzers market?

  • The blood gas and electrolyte analyzers market is expected to witness expansion owing to factors such as the increasing prevalence of chronic diseases like cardiovascular, respiratory, kidney diseases, and diabetes. These conditions are particularly common among the growing geriatric population, which is more prone to developing such ailments. Additionally, the rising adoption of Point-of-Care Testing (POCT) enables faster, on-site diagnosis, contributing to market growth. Technological advancements, such as smaller, portable, and automated analyzers, along with new product launches by key players.

4. Who are the key players operating in the Blood Gas and Electrolyte Analyzers market?

  • Some of the key market players operating in the blood gas and electrolyte analyzers market include Abbott Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Horiba Medical, Medica Corporation, Nova Biomedical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Sensa Core Medical, OPTI Medical Systems, Inc., B&E BIO-TECHNOLOGY CO., LTD., Scitek Global Co., Ltd., i-SENS, Inc., Techno MedicaCo., Ltd., Trivitron Healthcare, Randox Laboratories Ltd., Techno MedicaCo., Ltd., Infitek Co., Ltd., Chengdu Seamaty Technology Co., Ltd., and others.

5. Which region has the highest share in the Blood Gas and Electrolyte Analyzers market?

  • North America is expected to hold the largest market share of the blood gas and electrolyte analyzers market in 2024, among all the regions. This can be attributed to the increasing prevalence of chronic diseases such as cardiovascular conditions, respiratory disorders, and kidney diseases, which are more common among the growing geriatric population in the region. Additionally, the rising demand for rapid diagnosis, coupled with technological advancements and new product launches by key market players. The region's developed healthcare infrastructure and sophisticated medical facilities also play a significant role in driving the adoption of advanced diagnostic tools like blood gas and electrolyte analyzers, making North America the highest revenue generating region in this market.

Table of Contents

1. Blood Gas and Electrolyte Analyzers Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Blood Gas and Electrolyte Analyzers Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Blood Gas and Electrolyte Analyzers Market Key Factors Analysis

  • 5.1. Blood Gas and Electrolyte Analyzers Market Drivers
    • 5.1.1. The increasing prevalence of chronic diseases
    • 5.1.2. The growing geriatric population
    • 5.1.3. The rising adoption of Point-of-Care Testing (POCT)
    • 5.1.4. Technological advancements and new product launches by key players
  • 5.2. Blood Gas and Electrolyte Analyzers Market Restraints and Challenges
    • 5.2.1. High cost of blood gas and electrolyte analyzers
    • 5.2.2. Device malfunction and calibration errors
  • 5.3. Blood Gas and Electrolyte Analyzers Market Opportunity
    • 5.3.1. Integration of advanced technologies such as artificial intelligence, machine learning, and Internet of Things, among others with these devices
    • 5.3.2. Increasing demand and awareness about early and accurate diagnosis

6. Blood Gas and Electrolyte Analyzers Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Blood Gas and Electrolyte Analyzers Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Instruments
    • 7.1.2. Consumables
  • 7.2. By Type
    • 7.2.1. Portable
    • 7.2.2. Bench-top
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Laboratories
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.3.3. India Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Blood Gas and Electrolyte Analyzers Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Blood Gas and Electrolyte Analyzers Market Size In USD Million (2022-2032)

8. Blood Gas and Electrolyte Analyzers Market Company and Product Profiles

  • 8.1. Abbott Laboratories
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Siemens Healthineers AG
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Thermo Fisher Scientific Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Danaher Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. F. Hoffmann-La Roche Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Horiba Medical
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Medica Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Nova Biomedical
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Sensa Core Medical
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. OPTI Medical Systems, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. B&E BIO-TECHNOLOGY CO., LTD.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Scitek Global Co., Ltd.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. i-SENS, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Techno MedicaCo., Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Trivitron Healthcare
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Randox Laboratories Ltd.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Agilent Technologies, Inc.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Infitek Co., Ltd.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Chengdu Seamaty Technology Co., Ltd.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Blood Gas and Electrolyte Analyzers Market in Global (2022-2032)
  • Table 3: Blood Gas and Electrolyte Analyzers Market in Global by Product Type (2022-2032)
  • Table 4: Blood Gas and Electrolyte Analyzers Market in Global by Type (2022-2032)
  • Table 5: Blood Gas and Electrolyte Analyzers Market in Global by End-User (2022-2032)
  • Table 6: Blood Gas and Electrolyte Analyzers Market in Global by Geography (2022-2032)
  • Table 7: Blood Gas and Electrolyte Analyzers Market in North America (2022-2032)
  • Table 8: Blood Gas and Electrolyte Analyzers Market in the United States (2022-2032)
  • Table 9: Blood Gas and Electrolyte Analyzers Market in Canada (2022-2032)
  • Table 10: Blood Gas and Electrolyte Analyzers Market in Mexico (2022-2032)
  • Table 11: Blood Gas and Electrolyte Analyzers Market in Europe (2022-2032)
  • Table 12: Blood Gas and Electrolyte Analyzers Market in France (2022-2032)
  • Table 13: Blood Gas and Electrolyte Analyzers Market in Germany (2022-2032)
  • Table 14: Blood Gas and Electrolyte Analyzers Market in United Kingdom (2022-2032)
  • Table 15: Blood Gas and Electrolyte Analyzers Market in Italy (2022-2032)
  • Table 16: Blood Gas and Electrolyte Analyzers Market in Spain (2022-2032)
  • Table 17: Blood Gas and Electrolyte Analyzers Market in Rest of Europe (2022-2032)
  • Table 18: Blood Gas and Electrolyte Analyzers Market in Asia-Pacific (2022-2032)
  • Table 19: Blood Gas and Electrolyte Analyzers Market in China (2022-2032)
  • Table 20: Blood Gas and Electrolyte Analyzers Market in Japan (2022-2032)
  • Table 21: Blood Gas and Electrolyte Analyzers Market in India (2022-2032)
  • Table 22: Blood Gas and Electrolyte Analyzers Market in Australia (2022-2032)
  • Table 23: Blood Gas and Electrolyte Analyzers Market in South Korea (2022-2032)
  • Table 24: Blood Gas and Electrolyte Analyzers Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Blood Gas and Electrolyte Analyzers Market in Rest of the World (2022-2032)
  • Table 26: Blood Gas and Electrolyte Analyzers Market in the Middle East (2022-2032)
  • Table 27: Blood Gas and Electrolyte Analyzers Market in Africa (2022-2032)
  • Table 28: Blood Gas and Electrolyte Analyzers Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Blood Gas and Electrolyte Analyzers Market in Global (2022-2032)
  • Figure 3: Blood Gas and Electrolyte Analyzers Market in Global by Product Type (2022-2032)
  • Figure 4: Blood Gas and Electrolyte Analyzers Market in Global by Type (2022-2032)
  • Figure 5: Blood Gas and Electrolyte Analyzers Market in Global by End-User (2022-2032)
  • Figure 6: Blood Gas and Electrolyte Analyzers Market in Global by Geography (2022-2032)
  • Figure 7: Blood Gas and Electrolyte Analyzers Market in North America (2022-2032)
  • Figure 8: Blood Gas and Electrolyte Analyzers Market in the United States (2022-2032)
  • Figure 9: Blood Gas and Electrolyte Analyzers Market in Canada (2022-2032)
  • Figure 10: Blood Gas and Electrolyte Analyzers Market in Mexico (2022-2032)
  • Figure 11: Blood Gas and Electrolyte Analyzers Market in Europe (2022-2032)
  • Figure 12: Blood Gas and Electrolyte Analyzers Market in France (2022-2032)
  • Figure 13: Blood Gas and Electrolyte Analyzers Market in Germany (2022-2032)
  • Figure 14: Blood Gas and Electrolyte Analyzers Market in United Kingdom (2022-2032)
  • Figure 15: Blood Gas and Electrolyte Analyzers Market in Italy (2022-2032)
  • Figure 16: Blood Gas and Electrolyte Analyzers Market in Spain (2022-2032)
  • Figure 17: Blood Gas and Electrolyte Analyzers Market in Rest of Europe (2022-2032)
  • Figure 18: Blood Gas and Electrolyte Analyzers Market in Asia-Pacific (2022-2032)
  • Figure 19: Blood Gas and Electrolyte Analyzers Market in China (2022-2032)
  • Figure 20: Blood Gas and Electrolyte Analyzers Market in Japan (2022-2032)
  • Figure 21: Blood Gas and Electrolyte Analyzers Market in India (2022-2032)
  • Figure 22: Blood Gas and Electrolyte Analyzers Market in Australia (2022-2032)
  • Figure 23: Blood Gas and Electrolyte Analyzers Market in South Korea (2022-2032)
  • Figure 24: Blood Gas and Electrolyte Analyzers Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Blood Gas and Electrolyte Analyzers Market in Rest of the World (2022-2032)
  • Figure 26: Blood Gas and Electrolyte Analyzers Market in the Middle East (2022-2032)
  • Figure 27: Blood Gas and Electrolyte Analyzers Market in Africa (2022-2032)
  • Figure 28: Blood Gas and Electrolyte Analyzers Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis